Indian Journal of Endocrinology and Metabolism

POSITION STATEMENT
Year
: 2021  |  Volume : 25  |  Issue : 1  |  Page : 4--11

Diagnosis and management considerations in steroid-related hyperglycemia in COVID-19: A position statement from the endocrine society of India


Sambit Das1, Ashu Rastogi2, KV S. Harikumar3, Deep Dutta4, Rakesh Sahay5, Sanjay Kalra6, Sujoy Ghosh7, Sushil K Gupta8, Kaushik Pandit9, PK Jabbar10, Suresh Damodaran11, V Sri Nagesh12, Shehla Sheikh13, SV Madhu14, Ganapathi Bantwal15 
1 Professor of Endocrinology, Hi Tech Medical College and Hospitals, Bhubaneswar, Odisha, India
2 Department of Endocrinology, PGIMER, Chandigarh, India
3 Senior Consultant Endocrinologist, Magna Clinics, Hyderabad, Telangana, India
4 Department of Endocrinology, Cedar Superspecialty Clinics, Dwarka, New Delhi, India
5 Professor of Endocrinology, Osmania Medical College, Hyderabad, Telangana, India
6 Endocrinologist, Bharti Hospital, Karnal, Haryana, India
7 Department of Endocrinology, IPGME and R, Kolkata, West Bengal, India
8 Department of Endocrinology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, UP, India
9 Consultant Endocrinologist and Diabetologist, Fortis Medical Centre, Kolkata, West Bengal, India
10 Department of Endocrinology, Medical College Trivandrum, Trivandrum, Kerala, India
11 Consultant Diabetologist and Endocrinologist, Ramakrishna Hospital and Harvey speciality clinic, Coimbatore, Tamil Nadu, India
12 Endocrinologist, Srinagesh Diabetes, Thyroid and Endocrine Clinic, Hyderabad, Telangana, India
13 Consultant Endocrinologist, Nagpada-Mumbai Central, Mumbai, Maharashtra, India
14 Department of Endocrinology, University College of Medical Sciences and Guru Teg Bahadur Hospital, New Delhi, India
15 Professor of Endocrinology, St Johns Medical College and Hospital, John Nagar, Koramangala, Bengaluru, Karnataka, India

Correspondence Address:
Ganapathi Bantwal
Professor and Head, Department of Endocrinology, St Johns Medical College and Hospital, John Nagar, Koramangala, Bengaluru, Karnataka
India

The current coronavirus disease (COVID-19) pandemic is showing no signs of abatement and result in significant morbidity and mortality in the infected patients. Many therapeutic agents ranging widely between antivirals and anti-inflammatory drugs have been used to mitigate the disease burden. In the deluge of the drugs being used for COVID-19 infection, glucocorticoids (GCs) stand out by reducing mortality amongst in-hospital severe-to-critically ill patients. Health-care practitioners have seen this as a glimmer of hope and started using these drugs more frequently than ever in clinical practice. The fear of mortality in the short term has overridden the concern of adverse long-term consequences with steroid use. The ease of availability, low cost, and apparent clinical improvement in the short term have led to the unscrupulous use of the steroids even in mild COVID-19 patients including self-medication with steroids. The use of GCs has led to the increasing incidence of hyperglycemia and consequent acute complications of diabetic ketoacidosis and mucormycosis in COVID-19 patients. There is an urgent need to dissipate information about optimum management of hyperglycemia during steroid use. In view of this, the Endocrine Society of India has formulated this position statement about the diagnosis and management of hyperglycemia due to the use of GCs in patients with COVID-19 infection.


How to cite this article:
Das S, Rastogi A, S. Harikumar K V, Dutta D, Sahay R, Kalra S, Ghosh S, Gupta SK, Pandit K, Jabbar P K, Damodaran S, Nagesh V S, Sheikh S, Madhu S V, Bantwal G. Diagnosis and management considerations in steroid-related hyperglycemia in COVID-19: A position statement from the endocrine society of India.Indian J Endocr Metab 2021;25:4-11


How to cite this URL:
Das S, Rastogi A, S. Harikumar K V, Dutta D, Sahay R, Kalra S, Ghosh S, Gupta SK, Pandit K, Jabbar P K, Damodaran S, Nagesh V S, Sheikh S, Madhu S V, Bantwal G. Diagnosis and management considerations in steroid-related hyperglycemia in COVID-19: A position statement from the endocrine society of India. Indian J Endocr Metab [serial online] 2021 [cited 2021 Jul 25 ];25:4-11
Available from: https://www.ijem.in/article.asp?issn=2230-8210;year=2021;volume=25;issue=1;spage=4;epage=11;aulast=Das;type=0